{"entity":{"type":"insider","cik":"0001649483","url":"/insider/0001649483","json_url":"/insider/0001649483.json","name":"Charles Scott J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2016-05-16","last":"2017-07-28","span_basis":"filed_date"},"name_variants":[{"name":"Charles Scott J","source":"filing","n_filings":3,"first_seen":"2016-05-16","last_seen":"2017-07-28"}],"transactions":[{"id":4108285,"accession":"0001104659-17-047846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-047846","line_url":"/filing/0001104659-17-047846#line-1","is_derivative":false,"issuer_cik":"0001649483","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001649483","owner_cik":"0001649483","owner_name":"Charles Scott J","owner_display_name":"Charles Scott J","owner_url":"/insider/0001649483","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10804.0,"shares_display":"10,804","price_per_share":1.2504,"price_display":"1.25","price_state":"stated","total_value":13509.3216,"total_display":"13,509.32","total_whole":"13,509","shares_owned_after":280551.0,"shares_owned_after_display":"280,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-28","filed_date":"2017-07-28","scope":"insider"},{"id":4485504,"accession":"0001104659-17-018600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-018600","line_url":"/filing/0001104659-17-018600#line-1","is_derivative":false,"issuer_cik":"0001649483","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001649483","owner_cik":"0001649483","owner_name":"Charles Scott J","owner_display_name":"Charles Scott J","owner_url":"/insider/0001649483","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5205.0,"shares_display":"5,205","price_per_share":2.41,"price_display":"2.41","price_state":"stated","total_value":12544.05,"total_display":"12,544.05","total_whole":"12,544","shares_owned_after":208163.0,"shares_owned_after_display":"208,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-20","filed_date":"2017-03-22","scope":"insider"},{"id":2777789,"accession":"0001104659-16-121466","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-121466","line_url":"/filing/0001104659-16-121466#line-1","is_derivative":false,"issuer_cik":"0001649483","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001649483","owner_cik":"0001649483","owner_name":"Charles Scott J","owner_display_name":"Charles Scott J","owner_url":"/insider/0001649483","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Shares, without par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.4899,"price_display":"3.49","price_state":"stated","total_value":174495.0,"total_display":"174,495.00","total_whole":"174,495","shares_owned_after":213368.0,"shares_owned_after_display":"213,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-12","filed_date":"2016-05-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001660719","name":"Aralez Pharmaceuticals Inc.","url":"/issuer/0001660719","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2016-05-16","last_seen":"2017-07-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001649483","retrieved_at":"2026-08-25T18:09:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}